MarginsXMarginsX
Home › Markets › NIKA

Nika Pharmaceuticals, Inc (NIKA)

NIKA is quoted over the counter, not listed on an exchange. Nika Pharmaceuticals, Inc files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Last trade · October 28, 2026
$0.3500
No trades since Oct 28, 2026; later closes repeat the last quote
1-year return
+16.7%
Market cap
$369.1M
Small cap. From the Oct 28, 2026 last trade × 1.05B shares (10-Q cover page, Oct 15, 2026)
P/E and P/S
Net loss over the period · No revenue line filed
On trailing twelve months to September 30, 2026 (10-Q)

Closes: Yahoo Finance daily closes, last bar 2026-11-13.

Profile

FieldValue
TickerNIKA, quoted over the counter
SEC CIK0001145604
OTC Markets tierOTCQB (price source, 2026-11-13)
SEC industry codePharmaceutical Preparations
Business addressHenderson, NV
Incorporated inCO

Warning signs

Cash runway
0.1 months
$352 cash at September 30, 2026
Share count, 1 year
+1.4%
2025-11-07 to 2026-10-15 · +20.4% over 3 years
Going-concern doubt
Yes
10-Q filed November 10, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These factors raise substantial doubt about its ability to continue as a going concern."
10-Q 2026-11-10
Cash and burn$352 cash; operating cash flow -$18K a quarter.Report 2026-09-30
Shares outstanding1,054,689,224 (2026-10-15); 1,039,836,001 a year earlier; 876,090,000 three years earlier.Cover page 2026-10-15
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorBoladale Lawal & Co ( Chartered Accountants), lagos, NigeriaPCAOB Form AP 2026-04-06
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
Not filed-$13K-$11K$352$349KNeeds four quarters10-Q 2026-11-10
Q2 2026
2026-06-30
Not filed-$20K-$8K$3K$341KNeeds four quarters10-Q 2026-08-10
Q1 2026
2026-03-31
Not filed-$13K-$13K$2K$332KNeeds four quarters10-Q 2026-05-12
Q4 2025
2025-12-31
Not filed-$37K-$39K$2K$319KNeeds four quarters10-K 2026-03-25
Q3 2025
2025-09-30
Not filed-$8K-$9K$6K$284KNeeds four quarters10-Q 2026-11-10
Q2 2025
2025-06-30
Not filed-$18K-$19K$16K$284KNeeds four quarters10-Q 2026-08-10
Q1 2025
2025-03-31
Not filed-$13K-$13K$19K$269KNeeds four quarters10-Q 2026-05-12
Q4 2024
2024-12-31
Not filed-$12K-$28K$2K$239K$010-K 2026-03-25

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest annual report10-K2026-03-25
Latest quarterly / interim10-Q2026-11-10
Latest current report8-K2024-10-16

Source: SEC EDGAR submissions feed, 72 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier